Related Experiment Video
Updated: Aug 9, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Atorvastatin normalizes endothelial function in healthy smokers
1Department of Cardiology, Karolinska University Hospital, Karolinska Institute, S 14186 Stockholm, Sweden. stefan.agewall@karolinska.se
Insights
Atorvastatin treatment significantly improved endothelial function in smokers with normal cholesterol levels. This improvement in flow-mediated dilation (FMD) occurred independently of changes in LDL cholesterol, suggesting statins benefit smokers
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Endothelial Biology
Background:
- Endothelial dysfunction is a predictor of cardiovascular disease.
- Smokers often exhibit impaired endothelial function, even with normal lipid profiles.
- Statins are primarily known for lipid-lowering effects but may have pleiotropic vascular benefits.
Purpose of the Study:
- To investigate the effect of atorvastatin on endothelial function in smokers with normal cholesterol.
- To compare atorvastatin's impact on endothelial function between smokers and non-smokers.
- To determine if improvements in endothelial function are linked to LDL cholesterol reduction.
Main Methods:
- Open-label, randomized cross-over study involving 20 healthy smokers and 20 non-smokers.
- Participants received either 80 mg of atorvastatin or placebo.
- Endothelial function was assessed using flow-mediated dilation (FMD) measurements.
Main Results:
- Smokers had significantly lower baseline FMD compared to non-smokers (2.2% vs. 4.5%, P<0.05).
- Atorvastatin treatment increased FMD in smokers (to 4.0%, P<0.05), with levels returning to baseline during placebo.
- Atorvastatin had no significant effect on FMD in non-smokers, and changes in FMD were not correlated with LDL cholesterol reduction.
Conclusions:
- High-dose atorvastatin (80 mg) can improve endothelial function in smokers with normal lipid levels.
- The beneficial effect of atorvastatin on endothelial function in smokers is independent of its LDL-lowering capacity.
- Statin therapy may represent a therapeutic strategy to mitigate endothelial dysfunction associated with smoking.
Abstract:
Endothelial function is known to predict cardiovascular disease. The aim of the present study was to examine whether endothelial function in smokers with normal cholesterol levels could be normalized by treatment with 80 mg of atorvastatin in comparison with a control group. Healthy smokers (n=20) and non-smokers (n=20) were randomized to receive 80 mg of atorvastatin or placebo in an open randomized cross-over study, followed by measurement of endothelial functional [FMD (flow-mediated dilation)]. At baseline, smokers had a lower FMD compared with the non-smoking group (2.2+/-0.5 and 4.5+/-0.8% respectively; P<0.05). In the smoking group, FMD increased significantly (P<0.05) to 4.0+/-0.8% during treatment with atorvastatin and returned to basal levels during placebo (2.3+/-0.6%). In the non-smoking group, FMD was unaffected by both atorvastatin and placebo. The net change of total cholesterol or LDL (low-density lipoprotein)-cholesterol was not associated with the net change in FMD when the study group was considered as a whole or the smoking group was considered separately. In conclusion, improved endothelial function was observed in a group of smokers when they were received 80 mg of atorvastatin, whereas atorvastatin had no effect on endothelial function in the non-smoking group. The improved FMD among smokers was independent of the decrease in LDL-cholesterol during atorvastatin treatment. The results show that poor endothelial function in smokers with normal lipid levels can be improved by a statin treatment.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...